Dosimetric advantages of using multichannel balloons compared to single-channel cylinders for high-dose-rate vaginal cuff brachytherapy

被引:21
作者
Serrano, Nicholas [1 ]
Moghanaki, Drew [1 ,2 ]
Asher, David [1 ]
Karlin, Jeremy [1 ]
Schutzer, Matthew [1 ,2 ]
Chang, Michael [1 ,2 ]
Hagan, Michael P. [1 ,2 ]
机构
[1] Virginia Commonwealth Univ, Dept Radiat Oncol, Massey Canc Ctr, Richmond, VA 23221 USA
[2] Hunter Holmes McGuire VA Med Ctr, Dept Radiat Oncol, Richmond, VA 23249 USA
关键词
Endometrial carcinoma; Vaginal cuff brachytherapy; Multichannel balloon; LOCALIZED PROSTATE-CANCER; EXTERNAL-BEAM RADIOTHERAPY; PERMANENT SOURCE BRACHYTHERAPY; VOLUME HISTOGRAM ANALYSIS; RADIATION-THERAPY; LONG-TERM; GASTROINTESTINAL TOXICITY; AMERICAN BRACHYTHERAPY; MORBIDITY OUTCOMES; INTERMEDIATE-RISK;
D O I
10.1016/j.brachy.2016.04.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: To evaluate the dosimetric advantages of using multichannel balloons (MCBs) vs. single-channel cylinders (SCCs) for high-dose-rate vaginal cuff brachytherapy. METHODS AND MATERIALS: A total of 91 consecutive high-dose-rate vaginal cuff brachytherapy including 45 MCB and 46 SCC treatments were reviewed. The clinical target volume (CTV) was defined as a 0.5-cm uniform expansion of the applicator surface from vaginal apex for 3 cm. For dosimetric comparison, we normalized prescription dose per fraction to 700 cGy and optimized each plan to cover at least 90% of CTV. CTV-1 cm, the true vaginal cuff volume, was defined as proximal 1 cm of CTV from vaginal apex. Four quality indices including conformity index (CI), dose homogeneity index, dose nonuniformity index, and overdose index were compared. RESULTS: The CTV and CTV-1 cm were significantly larger for MCB cases compared to SCC cases. Evaluating CTV coverage, the mean dose homogeneity index and dose nonuniformity index were superior for MCB than SCC. No differences were noted regarding CI and overdose index between MCB and SCC cases. However, focusing on CTV-1 cm, the difference of CI became significant in favor of MCB cases. In addition, the mean point dose at 0.5-cm depth from the apex was significantly lower in SCC cases compared to cases by MCB treatment, indicating inadequate vaginal apex coverage by SCC treatment. CONCLUSIONS: Compared to SCC, MCB treats a larger volume and offers a more conformal and homogeneous target coverage. In addition, a lower dose at the vaginal apex due to SCCs source anisotropy can be minimized. (C) 2016 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:435 / 441
页数:7
相关论文
共 35 条
[1]   Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy [J].
Albert, M ;
Tempany, CM ;
Schultz, D ;
Chen, MH ;
Cormack, RA ;
Kumar, S ;
Hurwitz, MD ;
Beard, C ;
Tuncali, K ;
O'Leary, M ;
Topulos, GP ;
Valentine, K ;
Lopes, L ;
Kanan, A ;
Kacher, D ;
Rosato, J ;
Kooy, H ;
Jolesz, F ;
Carr-Locke, DL ;
Richie, JP ;
D'Amico, AV .
CANCER, 2003, 98 (05) :949-954
[2]   ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer [J].
Ash, D ;
Flynn, A ;
Battermann, J ;
de Reijke, T ;
Lavagnini, P ;
Blank, L .
RADIOTHERAPY AND ONCOLOGY, 2000, 57 (03) :315-321
[3]   Quality of life outcomes after brachytherapy for early stage prostate cancer [J].
Brandeis, JM ;
Litwin, MS ;
Burnison, CM ;
Reiter, RE .
JOURNAL OF UROLOGY, 2000, 163 (03) :851-857
[4]   American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy [J].
Davis, Brian J. ;
Horwitz, Eric M. ;
Lee, W. Robert ;
Crook, Juanita M. ;
Stock, Richard G. ;
Merrick, Gregory S. ;
Butler, Wayne M. ;
Grimm, Peter D. ;
Stone, Nelson N. ;
Potters, Louis ;
Zietman, Anthony L. ;
Zelefsky, Michael J. .
BRACHYTHERAPY, 2012, 11 (01) :6-19
[5]   American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer [J].
Frank, Steven J. ;
Arterbery, V. Elayne ;
Hsu, I-Chow Joe ;
Abdel-Wahab, May ;
Ciezki, Jay P. ;
Hahn, Noah M. ;
Mohler, James Lloyd ;
Moran, Brian J. ;
Rosenthal, Seth A. ;
Rossi, Carl J. ;
Yamada, Yoshiya ;
Merrick, Gregory .
BRACHYTHERAPY, 2011, 10 (05) :357-362
[6]   Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer [J].
Gelblum, DY ;
Potters, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :119-124
[7]   Urinary morbidity following ultrasound-guided transperineal prostate seed implantation [J].
Gelblum, DY ;
Potters, L ;
Ashley, R ;
Waldbaum, R ;
Wang, XH ;
Leibel, S .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (01) :59-67
[8]   The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: Morbidity outcomes from two prospective randomized multicenter trials [J].
Ghaly, M ;
Wallner, K ;
Merrick, G ;
True, L ;
Sutlief, S ;
Cavanagh, W ;
Butler, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (05) :1288-1293
[9]   I-125 versus Pd-103 for low-risk prostate cancer: Long-term morbidity outcomes from a prospective randomized multicenter controlled trial [J].
Herstein, A ;
Wallner, K ;
Merrick, G ;
Mitsuyama, H ;
Armstrong, J ;
True, L ;
Cavanagh, W ;
Butler, W .
CANCER JOURNAL, 2005, 11 (05) :385-389
[10]   Late rectal toxicity after prostate brachytherapy: Influence of supplemental external beam radiation on dose-volume histogram analysis [J].
Kalakota, Kapila ;
Rakhno, Eugenia ;
Pelizzari, Charles A. ;
Jani, Ashesh B. ;
Liauw, Stanley L. .
BRACHYTHERAPY, 2010, 9 (02) :131-136